TMDX Q1 2019 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$4B

Q1 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$5M+85.6% YoY

Gross Profit

$3M55.0% margin

Operating Income

-$6M-127.5% margin

Net Income

-$7M-147.5% margin

EPS (Diluted)

$-0.36

QoQ Revenue Growth

+31.9%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$57,000

Balance Sheet

Total Assets

$39M

Total Liabilities

$51M

Stockholders' Equity

-$13M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$3M	+85.6%
Gross Profit	$3M	$924,000	+178.5%
Operating Income	-$6M	-$5M	-24.7%
Net Income	-$7M	-$5M	-40.7%

Revenue Segments

OCS Heart Product

$2M41%

OCS Lung Product

$1M30%

OCS Liver Product

$1M29%

Geographic Segments

UNITED STATES

$3M63%

Non-US

$2M37%